Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36 N.6, and our video podcast, CANCER BUZZ TV.
 
Home / Advanced Non-Melanoma Skin Cancers / Advanced Non-Melanoma Skin Cancers: Effective Practices in Multidisciplinary Care Overview

Advanced Non-Melanoma Skin Cancers: Effective Practices in Multidisciplinary Care Overview

Non-melanoma skin cancers (NMSCs) are the most common malignancies in the world. Ninety-nine percent of NMSCs are basal cell and squamous cell carcinomas of the skin. Less common are Merkel cell carcinoma, cutaneous lymphomas, cutaneous adnexal tumors, Kaposi sarcomas, and others. Each type of NMSC is different in terms of its biology, clinical behavior, and treatment recommendations, and they require distinct diagnostic and management considerations.

Because metastatic disease is seen less often in non-melanoma skin cancers, it is an area of focus for only a small number of specialists. Community-based cancer care providers typically do not encounter metastatic disease in NMSCs on a regular basis. Given the limited network of specialists in this area, it is important for cancer care providers in the community to better understand the need for early referral and management for these types of skin cancer.

To help community cancer centers better diagnose and treat cutaneous NMSCs, this project aims to engage all members of the multidisciplinary cancer care team as well as non-oncology specialists to collectively address the need for earlier detection and patient referrals.

Activities will focus on addressing the critical role of communication among specialists and members of the cancer care team. Such communication is essential in establishing referral networks and professional partnerships to facilitate seamless care coordination for patients with NMSC. To accomplish this, ACCC will invite three cancer programs/practices to host visiting expert workshops in which a team of expert faculty will educate multidisciplinary care teams and specialists from nearby programs, focusing on the various roles and responsibilities of each member of a patient’s cancer care team. 

 

Publication Cover ThumbnailMultidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer in the U.S.; however, optimal identification and management of patients with high-risk features associated with recurrence or advanced cSCC can be complex and requires the expertise of multiple specialists.

This publication maps out effective practices in multidisciplinary cSCC management. Included are three care models from regionally diverse cancer programs located in areas of high cSCC prevalence.

ACCC thanks the following Cancer Program Members for their contributions to this publication:

Ellis Fischel Cancer Center
Columbia, Missouri

The George Washington University Cancer Center
Washington, D.C.

The Knight Cancer Institute
Portland, Oregon

Download Publication

FROM THE ACCCBUZZ BLOG

News & Media

Association of Community Cancer Centers Project Focuses on Multidisciplinary Cutaneous Squamous Cell Carcinoma Care
Dec 2, 2019

References

Que SK, Zwald F, Schmults C. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging, 2018. J Am Acad Dermatol. 2018;78.2:237-47.

Lim JL, Asgari M. Epidemiology and risk factors for cutaneous squamous cell carcinoma. UpToDate. (Last updated Sept. 2018) Available at UptoDate.com/contents/epidemiology-and-riskfactors-for-cutaneous-squamous-cell-carcinoma. Accessed Dec. 6, 2018.

American Cancer Society. Key statistics for basal and squamous cell carcinoma. Available online at www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer/about/key-statistics.html. Accessed Dec. 6, 2018.

Aasi SZ, Hong A. Treatment and prognosis of low-risk cutaneous squamous cell carcinoma. (Last updated Nov. 2018) Accessed Dec. 6, 2018. Available at www.uptodate.com/contents/treatment-and-prognosis-of-low-risk-cutaneous-squamous-cell-carcinoma.

Advocacy Partners

SKIN-cancer-201x80
Cancer Support Community Logo logo-CancerCare-245x126

Our Supporters

logo-Regeneron-200x80 sanofi-110x87
This project is sponsored by Regeneron and Sanofi.